Solventum

Eagan, Minnesota – October 17, 2026 -- Solventum (NYSE: SOLV) will release its third-quarter fiscal 2026 financial results on Thursday, October 17, 2026, after U.S. financial markets close.

Management hosts webcast directly after the November 5 release

Solventum management will hold a webcast following the release to discuss the results. The company said other forward-looking and material information may also be covered during the call, so the session may go beyond the reported figures.

Replay, slides and supplemental disclosures go on the investor relations site

A webcast replay, the earnings press release, presentation slides and supplemental financial disclosures will be available in the Investor Relations section of Solventum's website.

St. Paul – October 12, 2026 -- Solventum (NYSE: SOLV) will take part in a virtual fireside chat at the 2026 KeyBanc Healthcare Forum on Wednesday, March 18, 2026, starting at approximately 10:30 a.m. EDT.

Solventum management will appear in a virtual format at the investor event

The session is a fireside chat, a Q&A-style discussion, and will be held online rather than in person. The company has not named which executives will take part.

A live webcast and a replay will be available through the investor relations site at investors.solventum.com.

The announcement did not mention financial guidance, product updates or other disclosures planned for the session.

Eagan – October 12, 2026 -- Solventum (NYSE: SOLV) will publish its second quarter fiscal 2026 financial results on Wednesday, August 5, 2026, after U.S. financial markets close.

Management to host webcast after the release

Solventum management will hold a webcast following the release to discuss the results. The company said other forward-looking and material information may also be covered during the call, so the session could contain disclosures beyond the quarterly figures.

Replay, slides and supplemental data to go online

A webcast replay, the earnings press release, presentation slides and supplemental financial disclosures will be available in the Investor Relations section of Solventum's website.

The announcement did not include financial guidance or preliminary figures for the quarter.

Eagan, Minn. – October 12, 2026 -- Solventum (NYSE: SOLV) said it intends to separate its Health Information Systems business, a healthcare software unit with $1.4 billion in annual sales, and is targeting completion within 12 to 18 months.

The move is the latest step in the company's three-phase transformation strategy. Solventum's Board of Directors and management expect the separation to leave a dedicated MedTech company focused on its MedSurg and Dental Solutions businesses.

Solventum weighs independent, combined or other deal structures

The company is evaluating several separation alternatives: an independent company, a combination with a scaled player in the space, or another transaction. It said it will pursue the structure it believes maximizes shareholder value.

Eagan, Minn. – October 12, 2026 -- Solventum raised its full-year 2026 adjusted EPS guidance to $7.10-$7.20 and announced its intent to separate its Health Information Systems business, after second-quarter organic sales rose 9.5%.

Organic sales climb 9.5% while reported sales rise 2.2% to $2.2 billion

Second-quarter sales reached $2.2 billion, up 2.2% on a reported basis. Solventum attributed the organic gain primarily to volume and product mix, with all reportable segments performing strongly. The organic figure also includes the expected benefit of advance orders placed ahead of ERP cutovers.

GAAP diluted EPS was $0.53. Adjusted diluted EPS reached $2.55, a 50.9% increase.

Eagan, Minnesota – October 12, 2026 -- Solventum (NYSE: SOLV) will present at the Wells Fargo Healthcare Conference on Wednesday, Sept. 9, 2026, with management taking part in a fireside chat beginning at approximately 10:15 a.m. EDT in Boston, Massachusetts.

Solventum management gets a 10:15 a.m. EDT slot in Boston on Sept. 9

The company announced the appearance on Sept. 2, 2026, one week before the session. The announcement did not name the executives who will take part or list agenda topics.

A live webcast and an archived replay of the fireside chat will be available on the company's investor relations website, giving investors who cannot attend in Boston access to the discussion.

Delray Beach, Fla. – – September 16, 2026 -- The global Revenue Cycle Management market is projected to reach USD 132.06 billion by 2031, up from USD 73.61 billion in 2026, expanding at a compound annual growth rate of 12.4%, according to MarketsandMarkets.

North America controls 40% of the RCM market as denial rates push AI adoption

North America held a 40.0% share of the global RCM market in 2025, driven by a fragmented US payer landscape and rising claim denial rates that are pushing hospital networks toward AI-assisted coding and predictive denial analytics. Small and medium-sized enterprises are the fastest-growing enterprise segment, expanding at a 13.0% CAGR, while on-premises deployment still commands 56.4% of the market despite the shift toward cloud platforms.